FDA-Drug2018-08-22Class III
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Orexigen Therapeutics, Inc.
Hazard
Defective Container: Customer complaints of punctures in the bottle.
Sold states
Nationwide in the USA
Affected count
95,296 bottles
Manufactured in
3344 N Torrey Pines Ct Ste 200, La Jolla, CA, United States
Products
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1099-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief